RT @ericdeinmd: #RNL2023 AGATA trial showed benefit of Abatecept in GCA - 48 to 31% disease free survival Robert Spiera
Tweet Content
#RNL2023
AGATA trial showed benefit of Abatecept in GCA - 48 to 31% disease free survival
Robert Spiera
@RheumNow https://t.co/pPzbdTTvEi
Show on Archive Page
On
Display in Search Results
On
PDQ
Off